Multi-center randomized and controlled study of oral calcium carbonate suspension in the treatment of acid-related diseases
10.3760/cma.j.issn.0254-1432.2012.11.009
- VernacularTitle:碳酸钙口服混悬液治疗酸相关性疾病的多中心随机对照研究
- Author:
Xinlei WANG
;
Xiuli ZUO
;
Chongmei YANG
;
Jiyong LIU
;
Zibin TIAN
;
Yanqing LI
- Publication Type:Journal Article
- Keywords:
Calcium carbonate;
Suspensions;
Administration,oral;
Acid-base imbalance;
Gastric acid;
Treatment outcome
- From:
Chinese Journal of Digestion
2012;32(11):754-757
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and safety of oral calcium carbonate suspension and proton pump inhibitors (PPI) in symptoms relief of acid related diseases.Methods The multi-center,randomized and controlled study was carried out.A total of 400 acid-related diseases patients from 14 to 70 years old with at least one of moderate or severe symptoms such as acid regurgitation,epigastric pain,epigastric discomfort,upper abdominal burning or distension were equally divided into two groups and treated with oral calcium carbonate suspension or omeprazole enteric-coated tablets.The onset of symptoms relief of all patients of the first time after taking medicine was observed.The relief of clinical symptoms at the third day and seventh day after taking medicine was also observed.The adverse events were recorded.Analysis of variance was performed for statistical analysis.Results The onset of symptoms relief of oral calcium carbonate suspension group in acid regurgitation,epigastric pain,epigastric discomfort,upper abdominal burning or distension of the first time after taking medicine were significantly faster than those of PPI group (F=4.866,8.142,41.366,6.955,35.252; all P＜0.05).At the third day after taking medicine,the treatment efficiency of oral calcium carbonate suspension group and PPI group were 69.50％ and 72.50％,and at the seventh day the treatment efficiency of oral calcium carbonate suspension group and PPI group were 92.00％ and 96.50％.There was no significant difference in treatment efficiency and comprehensive efficacy between two groups at day three and seven after taking medicine (both P＞ 0.05).There were 14 cases of mild adverse events and two cases of moderate adverse events in oral calcium carbonate suspension group.There were 10 cases of mild adverse events in PPI group.There was no significant difference between two groups (P＞0.05).Conclusion Oral calcium carbonate suspension provides faster symptom relief than PPI and can effectively improve the symptoms of acid-related diseases.
